Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POSIBA: Biomarkers in KRAS Wild Type Advanced Colorectal Cancer Treated With Chemotherapy and Cetuximab
NCT01276379Phase 2Completed
- Sponsor
- GEMCAD
- Start
- Jan 2011
- Primary completion
- Mar 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in colorectal cancer (CRC), sponsored by GEMCAD. Started Jan 2011; status: completed.
02
Drugs
KL-140
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01276379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01276379.